Cancer patients and targeted therapy during COVID‐19 pandemic: A descriptive case series study

To evaluate the effectiveness of targeted therapy on preventing or treating COVID‐19, in this study, we want to share our experience about 14 patients (nine women, five men; average age, 59 years) who were treated with targeted therapy due to their underlying malignant disorders in our center.

Detalles Bibliográficos
Autores principales: Khodadadi, Kasra, Moghimi, Minoosh, Mansouri, Reza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576967/
https://www.ncbi.nlm.nih.gov/pubmed/36267821
http://dx.doi.org/10.1002/ccr3.6392
Descripción
Sumario:To evaluate the effectiveness of targeted therapy on preventing or treating COVID‐19, in this study, we want to share our experience about 14 patients (nine women, five men; average age, 59 years) who were treated with targeted therapy due to their underlying malignant disorders in our center.

Ejemplares similares